As expected, signaling of CD8+ T cells to dendritic cells and cancer cells was identified as a strong positive biomarker (in 14 and 10 of the 18 cancer types, respectively, Figure 4C), in line with the crucial role these cells play in the immune response and mediation of immunotherapy effects.88 This evidence concerns the gene CD8A and cancer.